Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
- Conditions
- Abortion, Induced
- Registration Number
- NCT00206193
- Lead Sponsor
- Atrium Medical Center
- Brief Summary
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Pregnant women by whom a termination of pregnancy is desired.
Exclusion Criteria
- Women with liver/kidney disease
- Women on long-term use of corticosteroids (> 6 months)
- Cardiovascular problems
- Therapy-resistant diabetic women
- Therapy-resistant asthma/bronchitis
- Thalassemia
- Ulcerative colitis
- Peptic ulcer disease
- Glaucoma
- Porphyria
- Allergic reaction to prostaglandin or mifepristone
- Women with a prior caesarian section or women with contractions at the start of the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of mifepristone and misoprostol in pregnancy termination compared to sulprostone?
How does the comparative effectiveness of mifepristone/misoprostol versus sulprostone impact induced abortion outcomes?
Which biomarkers are associated with successful termination using mifepristone and misoprostol in early pregnancy?
What are the adverse event profiles and management strategies for mifepristone/misoprostol versus sulprostone in pregnancy termination?
Are there combination therapies or competitor drugs that enhance efficacy or safety in medical abortion compared to mifepristone/misoprostol and sulprostone?
Trial Locations
- Locations (1)
Atrium Medisch Centrum
🇳🇱Heerlen, Limburg, Netherlands
Atrium Medisch Centrum🇳🇱Heerlen, Limburg, NetherlandsSuzanne HW Vonken, Dr.Principal Investigator